Research paper
CYP3A5 is the major cytochrome P450 3A expressed in human colon and colonic cell lines

https://doi.org/10.1016/S1382-6689(96)00075-0Get rights and content

Abstract

CYP3A is known to be expressed in liver, small intestine and colon. However, its isoform distribution (CYP3A4, 3A5 and 3A7) and inducibility have not been clearly elucidated in the colon. Therefore, we analyzed CYP3A in human colon and compared its expression and inducibility to the human colonic cell lines HT29 and Caco2, which were used as models. Patients suffered either from sigmoiditis or colonic adenocarcinoma. Patients as well as HT29 and Caco2 cells were treated with rifampicin. CYP3A protein expression was analyzed in the colon of patients and in the cells by immunoblot and by isoelectric focusing enabling separation of CYP3A isoforms, while mRNA expression was determined using specific reverse transcription-polymerase chain reaction. In both human colon and cells, CYP3A5 was the main isoform expressed at the protein and mRNA levels. Rifampicin treatment had no effect on CYP3A expression. HT29 and Caco2 cells exhibiting the same CYP3A expression and inducibility might therefore be useful in vitro models for studying xenobiotic metabolism in human colon.

References (48)

  • G Truan et al.

    Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5

    Gene

    (1993)
  • D Walker et al.

    Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide

    Biochem. Pharmacol.

    (1994)
  • P Beaune et al.

    Isolation and sequence determination of cDNA clone related to human cytochrome P-450 nifedipine oxidase

  • I Chantret et al.

    Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line CaCo2: evidence for a glucose dependant negative regulation

    J. Cell. Sci.

    (1994)
  • J Combalbert et al.

    Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxydase) as a product of P450 3A gene subfamily

    Drug. Metab. Dispos.

    (1989)
  • M Daujat et al.

    Inducibility and expression of class IA and IIIA cytochromes P450 in primary cultures of adult human hepatocytes

    Biochem. Pharmacol.

    (1990)
  • I De Waziers et al.

    Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues

    J. Pharmacol. Exp. Ther.

    (1990)
  • I De Waziers et al.

    Drug-metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samples

    Carcinogenesis

    (1991)
  • I De Waziers et al.

    Effect of ethanol, dexamethasone and RU486 on expression of cytochromes P450 2B, 2E, 3A and glutathione transferase π in rat hepatoma cell line (Fao)

    Pharmacogenetics

    (1992)
  • C Ged et al.

    The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450 IIIA induction

    Br. J. Clin. Pharmacol.

    (1989)
  • F.P Guengerich et al.

    Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes

    Chem. Res. Toxicol.

    (1991)
  • M Kitada et al.

    Metabolic activation of aflatoxin B1 and 2-amino-3-methylimidazo(4,5-f)-quinoline by human adult and fetal liver

    Cancer Res.

    (1990)
  • J Kolars et al.

    Identification of rifampicin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

    J. Clin. Invest.

    (1992)
  • J Kolars et al.

    CYP3A gene expression in human gut epithelium

    Pharmacogenetics

    (1994)
  • Cited by (41)

    • Co-culture model of Caco-2/HT29-MTX cells: A promising tool for investigation of phycotoxins toxicity on the intestinal barrier

      2021, Chemosphere
      Citation Excerpt :

      In fact, it has been documented that phase I enzymes play a role in PTX2 detoxification (Alarcan et al., 2017; Ferron et al., 2016b). As HT29-MTX cells do not express CYP (Carrière et al., 1994; Gervot et al., 1996; Mahler et al., 2009; Barlovatz-Meimon and Ronot, 2014), this may explain the greater sensitivity of HT29-MTX cells to PTX2 compared to Caco-2 cells. In contrast, a decrease of viability (around 20%) was reported in differentiated Caco-2 cells exposed to 200 nM PTX2 (Alarcan et al., 2019), indicating that Caco-2 cells alone seem to be more sensitive to PTX2 than in co-culture with HT29-MTX cells.

    • Metabolic Barrier of the Gastrointestinal Tract

      2018, Comprehensive Toxicology: Third Edition
    • Metabolic Barrier of the Gastrointestinal Tract

      2010, Comprehensive Toxicology, Second Edition
    View all citing articles on Scopus
    View full text